On Friday, Pfizer and BioNTech announced that they are postponing their application to the FDA for their COVID-19 vaccine to be approved for children ages six months to four years old. According to Axios, the companies said they “will wait for the three-dose data” because they “believe it may provide a higher level of protection in this
More
Today: March 29, 2024